Amgen CEO's retirement pay could register at $49M

Stock options and deferred compensation have built up a comfortable $49 million nest egg for retiring Amgen ($AMGN) CEO Kevin Sharer. Dow Jones reports, though, that Sharer's 2011 compensation slipped 11% to $18.9 million. Robert Bradway (photo), who is taking the helm at the world's biggest biotech, nabbed $7.1 million in compensation for 2011, also down from 2010. He's getting a $1.4 million salary for the new job. Story

 

Suggested Articles

Moderna’s shares shrunk by nearly 5% before the long holiday weekend Thursday after a report out by Stat said the biotech was delaying its trial.

Keep your post-pandemic trials on track: learn how the right clinical supply chain partner can help sponsors avoid trial disruption. Read now>>

Helsinn Group and MEI Pharma penned a near $500 million biobucks pact for experimental blood cancer drug pracinostat back in 2016.